FXH:NYE-First Trust Health Care AlphaDEX® Fund (USD)

ETF | Health |

Last Closing

USD 111.8621

Change

+0.42 (+0.37)%

Market Cap

USD 1.29B

Volume

0.02M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index. The index is a modified equal-dollar weighted index to objectively identify and select stocks from the Russell 1000® Index in the health care sector that may generate positive alpha relative to traditional passive-style indices through the use of the AlphaDEX® selection methodology.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-30 )

Largest Industry Peers for Health

Symbol Name Price(Change) Market Cap
XLV Health Care Select Sector SPDR..

+1.00 (+0.65%)

USD 41.71B
XLV Health Care Select Sector SPDR..

+1.00 (+0.65%)

USD 41.71B
FHLC Fidelity® MSCI Health Care In..

+0.46 (+0.64%)

USD 2.97B
FHLC Fidelity® MSCI Health Care In..

+0.46 (+0.64%)

USD 2.97B
XHE SPDR® S&P Health Care Equipme..

+0.67 (+0.75%)

USD 0.22B
XHE SPDR® S&P Health Care Equipme..

+0.67 (+0.75%)

USD 0.22B
IDNA iShares Genomics Immunology an..

+0.05 (+0.22%)

USD 0.14B
IDNA iShares Genomics Immunology an..

+0.05 (+0.22%)

USD 0.14B
SBIO ALPS Medical Breakthroughs ETF

+0.06 (+0.16%)

USD 0.11B
SBIO ALPS Medical Breakthroughs ETF

+0.06 (+0.16%)

USD 0.11B

ETFs Containing FXH

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 8.03% 26% F 50% F
Dividend Return 0.22% 22% F 3% F
Total Return 8.25% 31% F 42% F
Trailing 12 Months  
Capital Gain 15.81% 12% F 48% F
Dividend Return 0.38% 31% F 5% F
Total Return 16.19% 12% F 42% F
Trailing 5 Years  
Capital Gain 55.08% 55% F 71% C-
Dividend Return 0.97% 31% F 3% F
Total Return 56.05% 50% F 65% D
Average Annual (5 Year Horizon)  
Capital Gain 6.54% N/A N/A 60% D-
Dividend Return 6.65% N/A N/A 52% F
Total Return 0.11% N/A N/A 4% F
Risk Return Profile  
Volatility (Standard Deviation) 17.10% N/A N/A 59% D-
Risk Adjusted Return 38.87% N/A N/A 56% F
Market Capitalization 1.29B 75% C 59% D-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:

There is nothing we particularly dislike